Skip to content
Matrix Global Advisors
Matrix Global Advisors
  • Home
  • About
  • News
  • Our Work
  • Contact
  • Home
  • About
  • News
  • Our Work
  • Contact
Nov72017
Testimony

A Letter to the FDA Regarding iQOS, a Less Harmful Alternative to Cigarettes

Alex Brill and Sally Satel | Letter to commissioner of the FDA

Dear Dr. Gottlieb:

We are scholars at the American Enterprise Institute, a nonpartisan, nonprofit policy research entity. Dr. Satel is a practicing psychiatrist who has studied and researched a broad range of matters related to mental health policy and addiction, including tobacco harm reduction. Mr. Brill is an expert in public finance and health economics, with a concentration in the economic and public health implications of smoking and its alternatives. The views expressed here are ours alone and may or may not reflect the views of our colleagues.

Thank you for the opportunity to comment on the modified risk tobacco product (MRTP) applications by Philip Morris Products S.A. cited above under section 911(g) of the Federal Food, Drug and Cosmetic Act. Philip Morris is seeking approval to make specific claims about risks of its heat-not-burn (HNB) technology (commercially known as iQOS) relative to conventional cigarettes. We urge the FDA to expeditiously review these applications and permit the sale and marketing of iQOS to American consumers.

Read Here

November 7, 2017Category: Testimony

Post navigation

PreviousPrevious post:Relax, the Housing Market will be Fine After Tax ReformNextNext post:MGA’s Alex Brill Serves as a Panelist for Cato Institute’s Capitol Hill Briefing on “Home Stretch for Major Tax Reform?”
  • Analysis(27)
  • Books(2)
  • Events(13)
  • Interviews(33)
  • News(43)
  • Op-Eds(59)
  • Press Releases(2)
  • Testimony(18)
  • Almost-Speaker McCarthy
    November 23, 2020
  • Nursing Homes Prepare for Third COVID-19 Surge
    October 26, 2020
  • Impact of the Coronavirus Pandemic on Red, Blue, and Swing States
    October 20, 2020
  • Trump Roils Markets with Conflicting Statements on Pandemic Relief
    October 7, 2020

Website Design and Developed by DreamBig Creative